Literature DB >> 702652

Analysis of immunoprecipitated surface glycoproteins in measles virions and in membranes of infected cells.

T W Fenger, J W Smith, C Howe.   

Abstract

Measles viral envelope proteins were immune precipitated from membranes of infected cells and from purified virus and analyzed by polyacrylamide gel electrophoresis. Under reducing conditions, specific precipitates contained two major polypeptide bands, designated virus glycopeptides 1 and 2 (VGP-1 and VGP-2). Both polypeptides appeared to be glycosylated, as indicated by their incorporation of [(14)C]glucosamine in infected cells. VGP-2 appeared as a single band in specific precipitates of infected cells and as a double band in precipitates of purified virus. Trypsin treatment of infected cells showed that reduced VGP-2 may be composed of two unrelated polypeptides. One may be F(1), which is unglycosylated, and the other may correspond to the proteolytic cleavage product of VGP-1, which is glycosylated. The relation of VGP-1 and VGP-2 to smaller surface antigens (X and Y) obtained by tryptic treatment of infected cells remains to be elucidated. In cells taken at various times postinfection and analyzed for viral membrane proteins, VGP-1 was detected at all times, indicating that the input virus VGP-1 was inserted into the cell and could not be differentiated from newly synthesized VGP-1. VGP-2 was not detectable before 24 h postinfection. In precipitates of cells 4 h postinfection and of infected cells incubated at pH 5.8, an additional polypeptide band migrated immediately ahead of VGP-1. We conclude that VGP-2 (molecular weight, 42,000) possibly consists of two components, one of which is the tryptic cleavage product of VGP-1 and the other of which is the unglycosylated polypeptide, F(1).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 702652      PMCID: PMC354268     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

2.  Partial structural analysis of the oligosaccharide moieties of the vesicular stomatitis virus glycoprotein by sequential chemical and enzymatic degradation.

Authors:  J R Etchison; J S Robertson; D F Summers
Journal:  Virology       Date:  1977-05-15       Impact factor: 3.616

3.  A comparison of the polypeptides of four measles virus strains.

Authors:  W E Mountcastle; P W Choppin
Journal:  Virology       Date:  1977-05-15       Impact factor: 3.616

4.  Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells.

Authors:  M Homma; M Ouchi
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

5.  Isolation and characterization of two distinct types of HVJ (Sendai virus) spikes.

Authors:  K Shimizu; Y K Shimizu; T Koama; N Ishida
Journal:  Virology       Date:  1974-11       Impact factor: 3.616

6.  Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein.

Authors:  A Scheid; L A Caliguiri; R W Compans; P W Choppin
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

7.  Use of coomassie brilliant blue R250 for the electrophoresis of microgram quantities of parotid saliva proteins on acrylamide-gel strips.

Authors:  T S Meyer; B L Lamberts
Journal:  Biochim Biophys Acta       Date:  1965-08-24

8.  N-acetylneuraminic acid (NANA) in measles virus.

Authors:  P Dore-Duffy; C Howe
Journal:  Proc Soc Exp Biol Med       Date:  1978-04

9.  Intracellular synthesis of measles virus-specified polypeptides.

Authors:  S L Wechsler; B N Fields
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

10.  Glycoproteins of measles virus under reducing and nonreducing conditions.

Authors:  J M Hardwick; R H Bussell
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.